No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background:In animals, decades of research have shown that serotonin (5‐HT) is involved in endogenous pain inhibition systems, which are deficient in chronic pain disorders such as fibromyalgia (FM). In humans, there is preliminary evidence showing that 5‐HT is involved in the FM pathophysiology. In the current endophenotyping study, we sought to investigate, for the first time in humans, the relationships between the serotonin transporter promoter region (5‐HTTLPR) polymorphism and experimentally‐induced pain perception/inhibition in healthy controls (HC) and FM patients. Methods:Participants were 58 FM patients and 60 HC, who did not differ in age, sex or menstrual cycle. Thermal stimuli were used to measure pain thresholds. Pain inhibition was elicited using a tonic thermal test (Peltier thermode) administered before and after activation of the diffuse noxious inhibitory controls (DNIC) by means of a cold‐pressor test (CPT). Results:Thermal pain thresholds were higher in HC compared to FM patients. Pain ratings during the CPT were lower in HC, relative to FM patients. Also, DNIC efficacy was stronger in HC compared to FM patients. However, there was no relationship between 5‐HTTLPR and experimentally‐induced pain perception/inhibition. Discussion:Our results further confirm that FM is associated with thermal hyperalgesia and deficient DNIC. However, we found no evidence showing that the 5‐HTTLPR polymorphism influences pain perception and DNIC. Potential reasons for this negative result will be discussed. Further endophenotyping studies of 5‐HT‐related gene polymorphisms are required to ascertain the potential relationships between 5‐HT and human pain perception/inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Allelic Variation of Human Serotonin Transporter Gene Expression
Heils, A., Teufel, A., Petri, S., Stöber, G., Riederer, P., Bengel, D., & Lesch, K. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062621.x · Cited by 2,221
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition
Julien, N., Goffaux, P., Arsenault, P., & Marchand, S. (2005) · Pain · doi:10.1016/j.pain.2004.12.032 · Cited by 634
Self-citationMeeus, M., & Nijs, J. (2007) · Clinical Rheumatology · doi:10.1007/s10067-006-0433-9 · Cited by 541 · cited 2×
“Using thermal, mechanical and electrical stimuli, numerous studies showed that pain thresholds are diminished in FM patients, relative to healthy controls, indicative of hyperalgesia/allodynia (Meeus and Nijs, 2007; Price and Staud, 2005).”
BackgroundResultArnold, L. M., Hess, E. V., Hudson, J. I., Welge, J. A., Berno, S. E., & Keck, P. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)01089-0 · Cited by 261 · cited 1×
“Also, controlled clinical trials showed the efficacy of selective serotonin reuptake inhibitors in the treatment of FM (Anderberg et al., 2000; Arnold et al., 2002; Wolfe et al., 1994).”
BackgroundA Double-blind Placebo Controlled Trial of Fluoxetine in Fibromyalgia
Wolfe, F., Cathey, M. A., & Hawley, D. J. (1994) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749409103725 · Cited by 252 · cited 1×
“Also, controlled clinical trials showed the efficacy of selective serotonin reuptake inhibitors in the treatment of FM (Anderberg et al., 2000; Arnold et al., 2002; Wolfe et al., 1994).”
BackgroundAn experimental model to measure excitatory and inhibitory pain mechanisms in humans
Tousignant-Laflamme, Y., Pagé, S., Goffaux, P., & Marchand, S. (2008) · Brain Research · doi:10.1016/j.brainres.2008.06.120 · Cited by 182 · cited 1×
“By comparing the pain evaluation induced by the thermode, acquired before and after the cold-pressor test, we were able to measure the inhibitory effect of the DNIC response, as shown previously by our group (Potvin et al., 2008; Tousignant-Laflamme et al., 2008).”
ResultSelf-citation
Cited by
Conditioned Pain Modulation in Populations With Chronic Pain: A Systematic Review and Meta-Analysis
Lewis, G. N., Rice, D. A., & McNair, P. J. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.07.005 · Cited by 561
Lee, Y. C., Nassikas, N. J., & Clauw, D. J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3306 · Cited by 377
“association between these genes and fi bromyalgia [31, 36- 38 ].”
BackgroundRole of endogenous pain modulation in chronic pain mechanisms and treatment
Yarnitsky, D. (2015) · Pain · doi:10.1097/01.j.pain.0000460343.46847.58 · Cited by 346
Abnormal endogenous pain modulation is a shared characteristic of many chronic pain conditions
Staud, R. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.41 · Cited by 290
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 275
O'Brien, A. T., Deitos, A., Triñanes Pego, Y., Fregni, F., & Carrillo-de-la-Peña, M. T. (2018) · The Journal of Pain · doi:10.1016/j.jpain.2018.01.010 · Cited by 227
Potvin, S., & Marchand, S. (2016) · Pain · doi:10.1097/j.pain.0000000000000573 · Cited by 166
“analgesia in healthy controls, whereas it elicited barely any analgesia in patients with FM.(25,26,30) Moreover, as illustrated by”
BackgroundSelf-citationTemporal Summation of Pain Is Not Amplified in a Large Proportion of Fibromyalgia Patients
Potvin, S., Paul-Savoie, E., Morin, M., Bourgault, P., & Marchand, S. (2012) · Pain Research and Treatment · doi:10.1155/2012/938595 · Cited by 36
Self-citation
Metadata
- Authors
- Potvin, S., Larouche, A., Normand, E., de Souza, J. B., Gaumond, I., Marchand, S., & Grignon, S.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2010-08
- Volume
- 14
- Issue
- 7
- Pages
- 742-746
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W1988036797
- Cited by
- 71
- References
- 8
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.